Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

GET 30 DAYS FREE

Nancy Pelosi and House Democrats are making health policy a major issue in the new congress; now is the time to try Inside Health Policy. .

Sign up for 30 days of no-obligation access for all the essential news during this critical time -- you'll be able to choose one of our online services as part of your trial: Inside CMS, FDA Week, Health Exchange Alert or Inside Drug Pricing.

Home

Top Story

AAHomecare To White House: Keep Ventilators Out Of DME Bid Program

Durable medical equipment lobbyists took their fight against adding ventilators to the competitive bidding program to the White House Domestic Policy Council after vowing to pressure the administration and Congress to change the policy.

Latest News

The Kansas House of Representatives on Thursday (March 21) approved a modified version of Democratic Gov. Laura Kelly’s plan to expand Medicaid under the Affordable Care Act.

CMS says about 250 Medicare providers dropped out of the Bundled Payments for Care Improvement Advanced demonstration, and, after the March 1 deadline to withdraw without facing any financial risk, about 1,300 providers remain as part of about 1,100 participating entities– which the agency called robust participation.

The American Enterprise Institute and the Brookings Institution are pushing lawmakers to expand site-neutral pay to on-campus hospital outpatient departments, a call that was mirrored in the president’s fiscal 2020 budget.

A prominent consumer advocacy group and an FDA advisory committee chair are calling for FDA drug center chef Janet Woodcock to step down from her post in order to clear a path for the agency to revamp its regulation of opioids and implement recommendations made in 2017 by the National Academies of Sciences, Engineering, and Medicine.

A prominent consumer advocacy group and an FDA advisory committee chair filed a citizen petition on Thursday (March 21) demanding FDA slap an immediate moratorium on the approval of new opioids until it revamps its regulation and review of new opioids as recommended by the National Academies of Sciences, Engineering, and Medicine in 2017.

Stakeholders representing both industry and consumers called for a re-think of FDA’s generally-recognized-as-safe (GRAS) process, where companies can put a new ingredient in food without agency review.

FDA will kick off the start of a conversation with stakeholders on reforming dietary supplement law with a public meeting May 16, agency chief Scott Gottlieb tweeted Tuesday (March 19).

FDA Commissioner Scott Gottlieb said he will testify before Congress in support of FDA’s 2020 budget on April 3, before leaving the agency two days later.

The HHS budget doubles down on CMS’ plan to increase the use of encounter data as part of a bid to “eliminate excessive payment in Medicare Advantage,” despite plans’ opposition to using risk score calculations to cut back MA payments.